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Abstract: There is growing evidence that commonly applied chemotherapy regimens can be improved by intro-
ducing new, specific, active and low side-effect drugs, or by combining substances to obtain the required clinical
effect. The aim of the present study was to investigate the effects of imperatorin and cisplatin, applied separately
or in combination, on apoptosis, necrosis and autophagy induction in the human cervical carcinoma cell line
(HeLa). Imperatorin appeared to be a potent autophagy inducer, rather than a necrotic or apoptotic one. In
contrast, cisplatin induced mainly apoptosis and necrosis after 6 h and 24 h, while longer incubation resulted
only in necrosis induction. When HeLa cells were incubated with both drugs, autophagy appeared most fre-
quently, although to a smaller extent than that observed after imperatorin administered alone. At the molecular
level, autophagy was correlated with the presence of the cleaved form of microtubule-associated protein 1 light
chain LC3 — LC3II. It was also accompanied by the inhibition of heat shock proteins Hsp27 and Hsp72 expres-
sion. Our results indicate that imperatorin alone, or in combination with cisplatin, is mainly an autopahgy induc-
er in HeLa cells. (Folia Histochemica et Cytobiologica 2012, Vol. 50, No. 3, 381–391)
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Introduction
Imperatorin (IMP, 8-isopentenyloxypsoralene) be-
longs to the furanocoumarin family. It is a natural
compound occurring in lemon, lime oils and popular
culinary herbs like parsnip, fennel and parsley [1]. Im-
peratorin shows potent pharmacological activity and
has been studied for its anti-inflammatory and antitu-
mor properties. It has shown an antiproliferative ef-
fect on several cancer cell lines [2]. Suppression of cell
proliferation and induction of apoptosis have been
suggested as possible mechanisms for its anticancer
activity [3]. Imperatorin inhibits the expression of cy-
clin D1 and induces G0/G1 cell cycle arrest in HeLa
cells followed by apoptosis [4]. It also affects reactive
oxygen species (ROS) production, induces mitochon-
drial membrane depolarization, decreases the level of
antiapoptotic Bcl-2 and Bcl-x, and increases the pro-
apoptotic Bax expression. Imperatorin promotes re-
lease of cytochrome c and activation of caspase 3 be-
fore leading to apoptosis [5]. Significant pro-apoptotic
potential of imperatorin has also been confirmed by in
vivo studies with nude mice bearing human hepatoma
HepG2 cells [37]. In contrast, some authors have ob-
served a mutagenic effect of imperatorin and transfor-
mation of the mouse fibroblast cell line [6, 7].
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Cisplatin (CP, cis-dichlorodiammine-platinum
(II)) is an important chemotherapeutic agent widely
used in clinical treatment against several malignan-
cies like ovarian, cervical, testicular, bladder, lung,
gastric, head and neck cancers. At the molecular lev-
el, it interacts with cellular proteins and lipids and
forms DNA adducts causing cell cycle arrest in G2/M
phase [8–10]. It can also disturb cytoskeleton organi-
zation [11]. It may induce apoptosis through caspase
3-dependent and -independent signaling pathways. It
has been shown that alteration in caspase 3 expres-
sion and activity were associated with the develop-
ment of cellular resistance to cisplatin [12, 13]. There
are also several other factors responsible for such re-
sistance. One of them is heat shock proteins (Hsps)
overexpressed in nearly all classes of tumors [14–17].
These are molecular chaperones, controlling prop-
er folding of newly synthesized polypeptides, refold-
ing of misfolded proteins, and controlling translo-
cation through cell membranes protecting against
cell death [18–21]. Therefore, tumour cell resistance
to apoptosis is thought to be closely associated with
Hsps overexpression, which indicates poor progno-
sis. Up-regulation of small heat shock protein Hsp27
has been observed in multiple malignancies includ-
ing squamous cell carcinoma, gastric carcinoma,
ovarian carcinoma and acute myeloid leukemia.
High expression of Hsp72 has been reported in high
grade malignant tumors such as pancreatic cancer,
colorectal carcinoma, breast cancer, endometrial
cancer, osteosarcoma and renal cell tumors. Over-
expression of both proteins has also been found in
cisplatin resistant human ovarian and cervical tumor
cells [38]. Therefore, it seems that decreasing the
Hsps level in cancer cells would be beneficial to pa-
tients.
Another type of programmed cell death observed
in cancer cells is autophagy. This is caspase-inde-
pendent cell death characterized by the accumula-
tion of autophagic vacuoles in the cytoplasm accom-
panied by degradation of the Golgi apparatus and
ER, preceding destruction of the nucleus. Autoph-
agy is suppressed during the early stages of tumor
progression. Therapeutically increased autophagy
could represent an alternative way to destroy the
cancer [22].
It is known that natural bioactive compounds may
act in synergy with chemotherapeutics used in clini-
cal treatment in programmed cell death induction.
They also diminish the side effects of cytostatic drugs.
Thus, the aim of our study was to investigate the ef-
fects of imperatorin and cisplatin, applied alone or in
combination, on apoptosis, necrosis and autophagy
induction in HeLa cells.
Material and methods
Cells and culture conditions. Human cervix carcinoma cell
line (HeLa B, ECACC No 85060701) cultured in RPMI 1640
medium supplemented with 5% FBS (fetal bovine serum)
(v/v) was used in this study. Cells were seeded on cover slides
(for cell death detection) or in Falcon vessels (for heat shock
proteins, caspase 3 and LC3 identification), at a density of
1 × 105 cells/ml and incubated at 37°C in humidified atmo-
sphere with 5% CO2.
Drug treatment. Imperatorin was isolated from the fruits
of Angelica archangelica (Hofm) by column chromatogra-
phy [39]. Imperatorin at final concentrations of 50 μM,
100 μM, 150 μM, and 200 μM, and cisplatin (Sigma) at final
concentrations of 2 μM, and 5 μM were used in the experi-
ments. The drugs were dissolved in dimethyl sulfoxide
(DMSO, Sigma). The final concentration of DMSO in the
culture medium did not exceed 0.01%, which, as indicated
in preliminary experiments, did not influence cell viability
or the expression of the proteins studied.
Three variants of drug treatment were performed:
1. The first variant — HeLa cells were incubated only with
imperatorin or cisplatin for 6 h, 24 h and 48 h;
2. The second variant — imperatorin and cisplatin were
added to the culture medium at the same time and in-
cubated for 24 h;
3. The third variant — the cells were preincubated with im-
peratorin for 6 h followed by cisplatin treatment for the
next 18 h; — the cells were preincubated with cisplatin for
6 h followed by imperatorin addition for the next 18 h.
As a control, the cells were incubated with 0.01%
of DMSO.
Immunoblotting. After imperatorin and/or cisplatin treat-
ment, HeLa cells were lysed in a hot SDS-loading buffer
(125 mM Tris-HCl pH 6.8; 4% SDS; 10% glycerol;
100 mM DTT), boiled in a water bath for 10 min, centri-
fuged at 10,000 g for 10 min, and the supernatants were col-
lected. The protein concentration was determined using
the Bradford method [23], and samples of the superna-
tants containing 80 μg of proteins were separated by 10%
SDS-polyacrylamide gel electrophoresis [24], and subse-
quently transferred onto Immobilon P membrane (Sig-
ma). Following the transfer, the membrane was blocked
with 3% low fat milk in PBS for 1 h, and incubated over-
night with mouse monoclonal antibody anti-Hsp72 (SPA
810, StressGen) diluted 1:1,000, anti-Hsp27 (SPA 800,
StressGen) diluted 1:1,000, and rabbit antibodies anti-
caspase 3 active form (Sigma) diluted 1:500, anti-LC3
(Sigma) diluted 1:1,000. The membranes were washed
3 times for 10 min with PBS containing 0.05% Triton
X-100 (Sigma) and incubated for 2 h with a 1:30,000 dilu-
tion of alkaline phosphatase-conjugated anti-mouse IgG
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or anti-rabbit IgG (Sigma). The membranes were visual-
ized with an alkaline phosphatase substrate (5-bromo-4-
-chloro-3-indolylphosphate and nitro-blue tetrazolium,
Sigma) in a color development buffer (DMF, Sigma). The
data was normalized relative to b-actin (Sigma, working
dilution 1:2,000).
The level of protein expression was determined using
Bio-Profil Bio-1D Windows Application V.99.03 program.
Three independent experiments were performed.
Apoptosis detection with fluorochromes. For apoptosis
and necrosis identification, the cells were stained with
fluorescent dye Hoechst 33342 (Sigma) and propidium
iodide (Sigma), respectively [25]. Morphological analy-
sis was performed under a fluorescence microscope (Ni-
kon E — 800). Cells exhibiting blue fluorescent nuclei
(fragmented and/or with condensed chromatin) were in-
terpreted as apoptotic. Cells exhibiting pink fluorescent
nuclei were interpreted as necrotic. At least 1,000 cells
in randomly selected microscopic fields were counted un-
der the microscope. Each experiment was performed in
triplicate.
Detection of acidic vesicular organelles with acridine or-
ange. Autophagy is a process of sequestrating cytoplasmic
proteins into the lytic compartment and is characterized by
the formation and promotion of acidic vesicular organelles
(AVOs). To detect AVOs in HeLa cells treated with imper-
atorin and/or cisplatin, vital staining with acridine orange
was performed [26]. The cells were incubated with the fluo-
rochrome at a final concentration of 1 μg/ml for 15 min.
Typical orange acridine — positive cells exhibited granular
discretion of AVOs in the cytoplasm, indicative of autopha-
gosome formation. Morphological analysis was performed
under a fluorescence microscope (Nikon E — 800). At least
1,000 cells in randomly selected microscopic fields were
counted under the microscope. Each experiment was per-
formed in triplicate. The percentage of autophagic cells was
calculated as the number of cells with AVOs versus the to-
tal number of stained cells.
Combination index. Determination of drug synergy or an-
tagonism was quantified by the combination index (CI) [27].
CI provides a quantitative measure of the extent of drug
interaction and the numerical value was calculated as de-
scribed in this equation:
Cisplatin % + Imperatorin %
CI =
     Cisplatin/Imperatorin %
Cisplatin % and Imperatorin % mean the percentage
of dead cells after treatment with separate drugs, and Cis-
platin/Imperatorin % after treatment with both drugs.
CI = 1 indicates an additive effect, < 1 — synergy, while
> 1 — antagonism.
Statistical analysis. Data is presented as the mean of re-
sults ± SD coming from three independent experiments.
Statistical evaluation was performed with one-way Anova
test followed by Dunnet’s multiple comparison test. p < 0.05
compared to the control was taken to be the criterion of
significance.
Results
Effects of cisplatin and imperatorin on apoptosis,
necrosis and autophagy
For apoptosis, necrosis or autophagy estimation, con-
trol HeLa cells and cells treated with imperatorin and
cisplatin separately, or in combination, were stained
with Hoechst 33342, propidium iodide and acridine
orange, respectively.
Imperatorin appeared to be an effective autoph-
agy inducer rather than an apoptotic or necrotic one
(Figure 1A). Our studies revealed a correlation be-
tween the drug concentration, incubation time and
the number of autophagic cells. After 6 h of treat-
ment, a not very high, but statistically significant, in-
crease in the number of programmed dead cells was
observed only after 100 μM of imperatorin. The high-
est percentage (18%) of autophagic cells was observed
after 24 h of treatment with the 100 μM concentra-
tion of the drug. Higher concentrations were less ef-
fective, and a gradual decrease in the number of au-
tophagic cells was observed. After treatment with 200
μM, only about 6% of autophagic cells were found.
After 48 h of treatment, a higher level of autophagic
cells was observed after application of 150 μM of the
drug (about 16%) and a dramatically decreased level
when 200 μM was used.
In contrast to imperatorin, incubation of HeLa
cells with cisplatin at the concentrations of 2 μM and
5 μM was less effective in autophagy induction (Fig-
ure 1B). The 24 h and 48 h incubations resulted in
a significant increase in the number of apoptotic cells,
especially after treatment with 5 μM of the drug
(about 8%). After a longer incubation time, the apo-
ptosis level was sustained, but it was accompanied by
significant necrosis induction.
When HeLa cells were incubated with both drugs,
autophagy was observed most frequently, but to
a smaller extent than after treatment with imperatorin
alone (Figure 2, Table 1). The intensity of the process
depended on the drug concentrations and not signif-
icantly on the order of drug administration. Treatment
with imperatorin at a concentration of 100 μM and
cisplatin 2 μM was the most effective, and about
10–12% of autophagic cells were observed in each
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incubation variant (Figures 2A–C). Co-incubation of
HeLa cells with cisplatin 2 μM and imperatorin 150 μM
at the same time was toxic to the cell culture and about
25% of necrotic cells were observed (Figure 2A). Incu-
bation of HeLa cells with cisplatin 5 μM and imperator-
in at different concentrations was less effective in au-
tophagy induction than cisplatin 2 μM (Figures 2D–F).
The highest percentage of autophagic cells was noted
after treatment with 100 μM of imperatorin, especially
when HeLa cells were preincubated with cisplatin. In-
cubation with higher imperatorin concentrations result-
ed in strong necrosis in all the drug combinations stud-
ied. Neither drug, in all the combinations studied, had
a significant effect on apoptosis induction.
Effects of imperatorin and cisplatin on Hsp72,
Hsp27, caspase 3 and LC3 expression
Apoptosis and autophagy at the molecular level are char-
acterized by the expression of some marker proteins.
Thus, we decided to estimate the level of caspase 3, LC3
as well as selected heat shock protein expression.
Figure 1. The effects of different imperatorin (A) concentrations (0–200 μM) and cisplatin (B) concentrations (0–5 μM)
on the levels of apoptosis, necrosis and autophagy induction in HeLa cells after 6 h, 24 h and 48 h of treatment.
C — picture of autophagic cells stained with acridine orange after 24 h incubation with imperatorin (100 μM),
D — picture of apoptotic and necrotic cells stained with Hoechst 33342 and propidium iodide after 24 h simultaneous
incubation with cisplatin (5 μM) and imperatorin (150 μM), E — picture of apoptotic and necrotic cells stained with
Hoechst 33342 and propidium iodide after 24 h incubation with cisplatin (5 μM). *p < 0.05
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Heat shock proteins
The effects of imperatorin and cisplatin on the ex-
pression of Hsp27 and Hsp72 were drug- and con-
centration-dependent (Figures 3, 4). As shown in Fig-
ure 3, both drugs added to the culture medium, sepa-
rately or in combination, generally were good inhibi-
tors of Hsp27. Imperatorin was most potent after
24 h of treatment at the concentration of 100 μM (about
50%). Cisplatin diminished the protein level less ef-
fectively and  the greatest inhibition was observed
after 24 h and 48 h of incubation (about 80%). In the
case of the drug combinations, simultaneous treat-
ment of HeLa cells with imperatorin 150 μM and cis-
platin 5 μM resulted in strong (about 20%) inhibi-
tion of Hsp27. Overexpression was observed only in
one case — when HeLa cells were incubated with
imperatorin at the concentration of 50 μM for 24 h
(160%). In the case of Hsp72, imperatorin inhibited
the protein level only after 48 h of incubation with
150 μM and 200 μM (about 25%), while cisplatin had
no significant effect on the protein expression. A com-
bination of both drugs, significantly or not, generally
inhibited Hsp72 expression in all the variants stud-
ied. Overexpression was observed after 24 h of incu-
bation with 50 μM and 200 μM of imperatorin, and
after simultaneous treatment with cisplatin 5 μM and
imperatorin 50 μM.
Caspase 3 and LC3
The effect of imperatorin on the expression of pro-
apoptotic protein caspase 3 was time- and concentra-
tion-dependent (Figure 5A). After 6 h of treatment,
no impact of the drug on the protein expression was
observed, but longer incubation time (24 h) strongly
increased its level, with maximum effectiveness at 50
μM (about 300%). Treatment with 200 μM of impera-
torin had no effect on the protein expression. Increased
protein expression (about 150%) was observed only
after incubation with imperatorin 100 μM, but higher
concentrations diminished the protein level.
Cisplatin, at all the concentrations studied, had
no significant effect on caspase 3 expression and the
protein level was comparable with the control value
(Figure 5B).
The effects of both drugs on the level of caspase 3
expression were dependent on the concentration and
the sequence of drug treatment. When HeLa cells
were incubated with 100 μM of imperatorin and 2 μM
of cisplatin administered at the same time, overex-
pression of caspase 3 was observed (Figure 5C). Co-
incubation of cells with 2 μM of cisplatin and 150 μM
of imperatorin decreased the protein level. In the
variant with cisplatin preincubation, the level of the
protein was lower than the control one. In the case of
co-incubation of HeLa cells with cisplatin 5 μM and
Table 1. Combination index (CI) analysis of combined treatment of HeLa with imperatorin (IMP) and cisplatin (CP) for
24 hours. A — treatment with both drugs at the same time; B — cisplatin pretreatment followed by incubation with
imperatorin; C — imperatorin pretreatment followed by cisplatin incubation; CI > 1 antagonism; CI < 1 synergism;
CI = 1 additive effect
A IMP 50 μM IMP 100 μM IMP 150 μM
Ap Nk Aut Ap Nk Aut Ap Nk Aut
2 μM 3.5 2.3 2.2 2.3 2.3 1.6 2.3 0.3 6
CP
5 μM 5.5 2.7 1.6 2.7 4 4 1.6 0.6 2.3
CP
B IMP 50 μM IMP 100 μM IMP 150 μM
Ap Nk Aut Ap Nk Aut Ap Nk Aut
2 μM 2.3 2.3 1.3 3.5 3.5 1.7 2.3 2.3 6.3
CP
5 μM 2.8 2.8 1.6 5.5 2.7 1.5 3.7 0.3 2.6
CP
C IMP 50 μM IMP 100 μM IMP 150 μM
Ap Nk Aut Ap Nk Aut Ap Nk Aut
2 μM 1.4 1.4 1.2 2.3 3.5 1.9 2.3 2.3 6.3
CP
5 μM 5.5 4 1.3 5.5 2 2 3.7 0.7 3.6
CP
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imperatorin 50 μM, the level of caspase 3 was inhibit-
ed at all the variants of drug treatment (Figure 5D).
Inhibition was also observed when the cells were pre-
incubated with cisplatin followed by imperatorin treat-
ment at the concentrations of 100 μM and 150 μM.
When the cells were preincubated with imperatorin
at concentrations exceeding 50 μM, the level of
caspase 3 reached the control one. Overexpression
of the protein was observed after simultaneous treat-
ment of HeLa cells with 100 μM and 150 μM of im-
peratorin and 5 μM of cisplatin.
In the case of autophagy marker protein LC3, its
cleavage into two forms, LC3I and LC3II, was ob-
served after treatment with all the drug concentra-
tions used in all experimental variants (Figure 6).
Discussion
There are conflicting reports concerning the effect of
imperatorin on cancer cells. On the one hand, it has
been indicated that imperatorin may be mutagenic,
on the other hand, that it may inhibit mutagenesis
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Figure 2. The levels of apoptosis, necrosis and autophagy induction after 24 h incubation of HeLa cells with different
imperatorin concentrations and cisplatin 2 μM (A–C) or 5 μM (D–F); A, D — incubation with both drugs at the same
time, B, E — preincubation with imperatorin, followed by cisplatin treatment, C, F — preincubation with cisplatin,
followed by imperatorin treatment. *p < 0.05
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and cancerogenesis [6, 7]. Induction of programmed
cell death, like apoptosis and autophagy, is regarded
as an important factor of cancerogenesis action. Thus,
we decided to examine the effect of imperatorin on
apoptosis, necrosis and autophagy in HeLa cells. Our
results indicate that imperatorin was a potent autoph-
agy inducer, especially at the concentration of 100 μM
after 24 hours of treatment and 150 μM after 48 h.
A shorter incubation time was less effective. In con-
trast, cisplatin itself did not induce autophagy. At the
molecular level, autophagy induction was correlated
with specific expression of marker protein LC3. It is
known that the cleavage of LC3 into two forms, LC3I
and LC3II, is the hallmark of autophagy. LC3II par-
ticipates in autophagosome formation and is associ-
ated with its structure. Accordingly, autophagy is as-
sociated with an increased ratio of LC3II to LC3I [28].
Several articles have appeared suggesting that in-
duction of autophagy may block apoptosis [29]. In our
experiments, imperatorin was a weak apoptosis in-
ducer. Interestingly, it was correlated with strong
caspase 3 expression, especially after 24 h and 48 h
of treatment. It has been shown by other authors
that imperatorin isolated from Cnidii monnieri fruc-
tus caused formation of apoptotic bodies, DNA frag-
mentation and enhanced degradation in HL-60 cells
[30]. This was accompanied by activation of the cy-
tochrome c-dependent pathway, mitochondrial
membrane potential perturbation, release of cyto-
chrome c, and in consequence, activation of caspase
3 and 9 [31]. Cisplatin induced apoptosis significantly
only after 5 μM. It is known that cisplatin can in-
duce apoptosis in caspase 3-dependent and -inde-
pendent manners [12, 13]. In our experiments, the
activation of caspase 3 was not significant. The mech-
anism involved in resistance of tumor cells to cispl-
atin is not clearly understood. It is supposed that
the induction of resistance may be associated with
decreased cellular cisplatin accumulation, enhanced
DNA repair and increased glutathione (GSH) or
Figure 3. The effects of imperatorin (I) and cisplatin (C) on the level of Hsp27 expression. A — HeLa cells incubated with
imperatorin (0–200 μM), B — cells incubated with cisplatin (0–5 μM), C — cells incubated with different imperatorin
concentrations and cisplatin 2 μM, D — cells incubated with different imperatorin concentrations and cisplatin 5 μM;
C+I — incubation with both drugs at the same time, IC — preincubation with imperatorin, followed by cisplatin treat-
ment, CI — preincubation with cisplatin, followed by imperatorin treatment. *p < 0.05
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increased Hsps levels [32, 33]. In our experiments,
cisplatin had no significant impact on Hsp72 expres-
sion and inhibited Hsp27 at the concentration of 5 μM
after 24 h and 48 h of treatment. At these concentra-
tions, apoptosis as well as necrosis was observed, which
may suggest the involvement of Hsp27 in cisplatin re-
sistance of HeLa cells to death.
Many studies have demonstrated that natural plant
extracts and natural compounds exhibit a synergistic
anti-tumor effect with chemotherapeutics [34, 35].
Thus, we decided to examine the effect of imperator-
in on the cisplatin-induced apoptosis of HeLa cells.
We measured cell death in HeLa cells pretreated with
imperatorin or cisplatin followed by cisplatin or im-
peratorin treatment and compared the effect to cell
death induced by cisplatin and imperatorin used si-
multaneously. In our experiments, the combination
of both drugs was most effective in autophagy induc-
tion, especially when imperatorin at the concentra-
tion of 100 μM was present in the drug mixture. Sim-
Figure 4. The effects of imperatorin (I) and cisplatin (C) on the level of Hsp72 expression. A — HeLa cells incubated with
imperatorin (0–200 μM), B — cells incubated with cisplatin (0–5 μM), C — cells incubated with different imperatorin
concentrations and cisplatin 2 μM, D — cells incubated with different imperatorin concentrations and cisplatin 5 μM;
C+I — incubation with both drugs at the same time, IC — preincubation with imperatorin, followed by cisplatin treat-
ment, CI — preincubation with cisplatin, followed by imperatorin treatment. *p < 0.05
ilar results were observed after imperatorin itself.
Surprisingly, the effectiveness of autophagy induction
was smaller in the case of the combination than in
the case of imperatorin alone. This may suggest that
cisplatin diminishes the pro-autophagal properties of
imperatorin. Autophagy induction was correlated with
the increased level of cleaved form LC3II. Inhibition
of Hsp72 and Hsp27 was also observed.
Neither drug at all the combinations had a signif-
icant effect on apoptosis induction. Only after simul-
taneous treatment of imperatorin over 100 μM with
cisplatin 5 μM was an increased level of apoptotic
cells observed. It was correlated with an increased
level of caspase 3. Unfortunately, this was also ac-
companied by strong necrosis induction, suggesting
a toxic effect of both drugs on the cell line. Our ear-
lier results strongly suggested that the significant
decrease in Hsp72 expression after pretreatment
with a natural flavonoid, quercetin, was correlated
with the highest sensitivity of HeLa cells to cispl-
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Figure 5. The effects of imperatorin (I) and cisplatin (C) on the level of caspase 3 expression. A — HeLa cells incubated
with imperatorin (0–200 μM), B — cells incubated with cisplatin (0–5 μM), C — cells incubated with different imperatorin
concentrations and cisplatin 2 μM, D — cells incubated with different imperatorin concentrations and cisplatin 5 μM;
C+I — incubation with both drugs at the same time, IC — preincubation with imperatorin, followed by cisplatin treat-
ment, CI — preincubation with cisplatin, followed by imperatorin treatment. *p < 0.05
atin-induced apoptosis [36]. In the present study, the
inhibition of Hsp72 as well as Hsp27 by imperatorin
was correlated with increased sensitivity to autoph-
agy rather than apoptosis.
In summary, our results indicated that imperator-
in alone, or in combination with cisplatin, was very
effective in inducing autophagy in HeLa cells. The
pro-autophagic activity of imperatorin was mediated
by LC3 cleavage and the inhibition of heat shock pro-
teins expression, especially Hsp27.
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